NLTX - Neoleukin Therapeutics Inc. (NLTX) CEO Jonathan Drachman on Q2 2020 Results - Earnings Call Transcript
Neoleukin Therapeutics, Inc. (NLTX)
Q2 2020 Earnings Conference Call
August 12, 2020 4:30 PM ET
Company Participants
Julie Rathbun - Communications
Jonathan Drachman - Chief Executive Officer
Bob Ho - Chief Financial Officer
Daniel-Adriano Silva - Head of Research
Carl Walkey - Vice President of Corporate Development
Umut Ulge - Vice President of Clinical Development
Conference Call Participants
Tyler Van Buren - Piper Sandler
Greg Harrison - Bank of America Securities
Robert Burns - H.C. Wainwright
Mara Goldstein - Mizuho Securities
Presentation
Operator
Good morning and thank you for joining us today for the Neoleukin